[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Cryoport Inc (CYRX)

Cryoport Inc (CYRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Cryoport Reports First Quarter 2026 Financial Results

NASHVILLE, Tenn. , May 4, 2026 /PRNewswire/ -- Cryoport, Inc. (NASDAQ: CYRX) ("Cryoport" or the "Company"), a leading global provider of integrated temperature-controlled supply chain solutions...

CYRX : 15.12 (+7.85%)
Cryoport's Path to Profitability Depends on What Happens Between Now and June

Barchart Research What to Expect from CYRX Earnings CYRX Generated May 1, 2026 Current Price $10.34 EPS Estimate $$-0.20 Consensus Rating Strong Buy Average Move 14.70% Cryoport's Path to Profitability...

CYRX : 15.12 (+7.85%)
Cryoport's Path to Profitability Depends on What Happens Between Now and June

Barchart Research What to Expect from CYRX Earnings CYRX Generated May 1, 2026 Current Price $10.34 EPS Estimate $$-0.20 Consensus Rating Strong Buy Average Move 14.70% Cryoport's Path to Profitability...

CYRX : 15.12 (+7.85%)
Cryoport's Path to Profitability Depends on What Happens Between Now and June

Barchart Research What to Expect from CYRX Earnings CYRX Generated May 1, 2026 Current Price $10.34 EPS Estimate $$-0.20 Consensus Rating Strong Buy Average Move 14.70% Cryoport's Path to Profitability...

CYRX : 15.12 (+7.85%)
Cryoport to Report First Quarter 2026 Financial Results on May 4, 2026

NASHVILLE, Tenn. , April 20, 2026 /PRNewswire/ -- Cryoport, Inc. (Nasdaq: CYRX) ("Cryoport" or the "Company"), a leading global provider of integrated temperature-controlled supply chain solutions...

CYRX : 15.12 (+7.85%)
Cryoport Reports Fourth Quarter and Full-Year 2025 Financial Results

NASHVILLE, Tenn. , March 3, 2026 /PRNewswire/ --  Cryoport, Inc.  (NASDAQ: CYRX) ("Cryoport" or the "Company"), a leading global provider of integrated temperature-controlled supply chain...

CYRX : 15.12 (+7.85%)
Cryoport's MVE Biological Solutions Introduces New Fusion® 800 Series

Self-Sustaining Fusion® 800 Series   Cryogenic Freezer Delivers High-Capacity Storage, Flexibility, and Cost Benefits in Limited Space Environments

CYRX : 15.12 (+7.85%)
Cryoport Reports Third Quarter 2025 Financial Results

NASHVILLE, Tenn. , Nov. 4, 2025 /PRNewswire/ --  Cryoport, Inc.  (NASDAQ: CYRX) ("Cryoport" or the "Company"), a leading global provider of temperature-controlled supply chain solutions for...

CYRX : 15.12 (+7.85%)
Cryoport Continues to Set New Benchmarks for the Global Regenerative Medicine Supply Chain

First Global Supply Chain Solutions Company to Achieve ISO 21973 Certification, Ensuring Highest Transport Safety, Traceability, and Integrity Standards for Cell and Gene Therapies

CYRX : 15.12 (+7.85%)
Cryoport to Report Third Quarter 2025 Financial Results on November 4, 2025

NASHVILLE, Tenn. , Oct. 21, 2025 /PRNewswire/ -- Cryoport, Inc. (Nasdaq: CYRX) ("Cryoport" or the "Company"), a global leader in temperature-controlled supply chain solutions for the...

CYRX : 15.12 (+7.85%)

Barchart Exclusives

Prepare for a Volatile Ride Ahead in Lam Research Stock After 278% Gains
Lam Research (LRCX) demonstrates strong technical momentum with a 278% gain over the past year. LRCX is supported by robust fundamentals. Valuation is elevated and Morningstar notes that the stock is 46% overvalued. For new buyers, this means you should proceed with caution and tight stop losses. Analyst sentiment is... Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.